Advanced
  Home Compare Reports

Comparison with Similar Reports

In-Vitro Diagnostics Market by Product & Service (Instrument, Kits), Technology (Immunoassay, MDx, Hematology, Urinalysis), Application (Diabetes, Onc...

by Product & Service (Instrument, Kits), Technology (Immunoassay, MDx, Hematology, Urinalysis), Application (Diabetes, Oncology, Cardiology, Nephrology, Infectious Diseases) End User (Hospitals)

Publisher:        MarketsandMarkets

# of Pages:        351

Rating: 

1 User License $4,950

Publication Date:  November, 2020

Price:       $4,950 / User License




TABLE OF CONTENTS

 

1              INTRODUCTION                35

1.1          OBJECTIVES OF THE STUDY          35

1.2          MARKET DEFINITION      35

1.3          MARKET SCOPE                35

1.3.1      INCLUSIONS AND EXCLUSIONS  35

1.4          MARKETS COVERED        36

1.5          YEARS CONSIDERED FOR THE STUDY        36

1.6          CURRENCY          37

TABLE 1                EXCHANGE RATES UTILIZED FOR THE CONVERSION TO USD          37

1.7          LIMITATIONS     37

1.8          STAKEHOLDERS 37

1.9          SUMMARY OF CHANGES              38

2              RESEARCH METHODOLOGY         39

2.1          RESEARCH APPROACH   39

2.1.1      RESEARCH DESIGN          39

2.1.2      SECONDARY RESEARCH 40

2.1.2.1   Key data from secondary sources             41

2.1.3      PRIMARY RESEARCH       41

2.1.4      PRIMARY SOURCES         41

2.1.4.1   Key data from primary sources  43

2.1.4.2   Breakdown of Primaries               43

FIGURE 1             BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION           43

FIGURE 3             SUPPLY SIDE ANALYSIS: IVD MARKET (2019)        45

FIGURE 4             DEMAND SIDE APPROACH: RAPID TEST MARKET SIZE (2019)        46

FIGURE 7             CAGR PROJECTIONS FROM THE ANALYSIS OF MARKET DRIVERS, RESTRAINTS< OPPORTUNITIES & CHALLENGES OF THE IVD

 INDUSTRY (2019-2025)  48

2.6          COVID-19 HEALTH ASSESSMENT                50

2.7          COVID-19 ECONOMIC ASSESSMENT        51

2.8          ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO          51

3              EXECUTIVE SUMMARY  54

FIGURE 11           IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 

2020 VS. 2025 (USD MILLION)     54

FIGURE 12           IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 

2020 VS. 2025 (USD MILLION)     55

FIGURE 13           IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY, 

2020 VS. 2025 (USD MILLION)     55

FIGURE 14           IN VITRO DIAGNOSTICS MARKET, BY END USER,

2020 VS. 2025 (USD MILLION)     56

FIGURE 15           GEOGRAPHIC SNAPSHOT OF THE IN VITRO DIAGNOSTICS MARKET           57

4              PREMIUM INSIGHTS       58

4.1          IN VITRO DIAGNOSTICS MARKET OVERVIEW       58

FIGURE 16           RISING INCIDENCE OF CHRONIC & INFECTIOUS DISEASES IS DRIVING THE GROWTH OF THE IN VITRO DIAGNOSTICS MARKET 58

4.2          ASIA PACIFIC: IN VITRO DIAGNOSTICS MARKET,  BY PRODUCT &

SERVICE AND COUNTRY (2019)  59

4.3          IN VITRO DIAGNOSTICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES          60

FIGURE 17           THE MARKET IN CHINA IS PROJECTED TO REGISTER THE HIGHEST CAGR IN THE IN VITRO DIAGNOSTICS MARKET DURING THE FORECAST PERIOD              60

4.4          GEOGRAPHIC MIX: IN VITRO DIAGNOSTICS MARKET       61

FIGURE 18           APAC TO WITNESS THE HIGHEST GROWTH IN THE FORECAST PERIOD       61

4.5          IN VITRO DIAGNOSTICS MARKET: DEVELOPED VS. DEVELOPING MARKETS            61

FIGURE 19           DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH DURING THE FORECAST PERIOD            61

5              MARKET OVERVIEW       62

5.1          INTRODUCTION                62

5.2          MARKET DYNAMICS       62

FIGURE 20           IN VITRO DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES     62

5.2.1      DRIVERS               63

5.2.1.1   Rising geriatric population and subsequent growth in the prevalence of chronic and infectious diseases 63

TABLE 2                ESTIMATED INCREASE IN THE GERIATRIC POPULATION, BY REGION

(2019–2050)       63

5.2.1.2   Increasing adoption of fully automated and POC instruments in developed regions          64

5.2.1.3   Growing awareness regarding disease diagnosis in developing regions   64

5.2.1.4   Growing R&D investments by industry players to launch new IVD products          65

5.2.2      RESTRAINTS       65

5.2.2.1   Unfavorable reimbursement scenario    65

5.2.3      OPPORTUNITIES               65

5.2.3.1   Development of condition-specific markers and tests     65

TABLE 3                NEW TESTS LAUNCHED BY KEY PLAYERS 66

5.2.3.2   Growing significance of companion diagnostics  66

5.2.3.3   Growth opportunities in emerging countries       67

5.2.4      CHALLENGES      67

5.2.4.1   Changing regulatory landscape  67

5.2.4.2   Operational barriers faced in conducting diagnostic tests               67

5.2.5      IMPACT OF COVID-19 ON THE IVD MARKET         68

6              INDUSTRY INSIGHTS       70

6.1          INTRODUCTION                70

6.2          PORTER’S FIVE FORCES ANALYTICAL FRAMEWORK           70

6.3          PESTLE ANALYSIS             71

6.4          INDUSTRY ECOSYSTEM ANALYSIS             72

6.5          INDUSTRY TRENDS          72

6.5.1      AUTOMATION OF CLINICAL LABORATORY TECHNIQUES 72

6.5.2      MICROFLUIDICS-BASED POC AND LAB-ON-A-CHIP DIAGNOSTIC DEVICES FOR LABORATORY TESTING      73

6.5.3      GROWING NUMBER OF REAGENT RENTAL AGREEMENTS              73

6.6          REGULATORY OVERVIEW             74

6.6.1      US          74

TABLE 4                US: CLASSIFICATION OF IN VITRO DIAGNOSTIC DEVICES                74

FIGURE 21           US: REGULATORY PROCESS FOR IVD DEVICES      75

6.6.2      CANADA              76

FIGURE 22           CANADA: REGULATORY PROCESS FOR IVD DEVICES IN CANADA 76

6.6.3      EUROPE               77

TABLE 5                EUROPE: CLASSIFICATION OF IVD DEVICES           77

FIGURE 23           EUROPE: REGULATORY PROCESS FOR IVD DEVICES           78

6.6.4      JAPAN  79

FIGURE 24           REGULATORY PROCESS FOR IVD DEVICES IN JAPAN         79

TABLE 6                JAPAN: CLASSIFICATION OF IVD REAGENTS CLASSIFICATION OF IVD REAGENTS IN JAPAN             80

TABLE 7                JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS         80

6.6.5      CHINA   80

TABLE 8                CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS         80

6.6.6      INDIA    81

FIGURE 25           INDIA: REGULATORY PROCESS FOR IVD DEVICES               81

6.6.7      INDONESIA         82

TABLE 9                INDONESIA: REGISTRATION PROCESS FOR IVD DEVICES 82

6.6.8      RUSSIA 83

TABLE 10              RUSSIA: CLASSIFICATION OF IVD DEVICES            83

6.6.9      SAUDI ARABIA  83

TABLE 11              SAUDI ARABIA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS         83

6.6.10    MEXICO               84

FIGURE 26           MEXICO: REGULATORY PROCESS FOR IVD DEVICES           84

TABLE 12              MEXICO: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS      84

6.6.11    BRAZIL  85

FIGURE 27           BRAZIL: REGULATORY PROCESS FOR IVD DEVICES             85

6.6.12    SOUTH KOREA   86

TABLE 13              SOUTH KOREA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS         86

6.7          VENDOR BENCHMARKING           86

TABLE 14              IN VITRO DIAGNOSTIC PRODUCTS & SERVICES MARKET: PRODUCT PORTFOLIO ANALYSIS             86

7              IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE            88

7.1          INTRODUCTION                89

TABLE 15              IVD MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)             89

7.2          REAGENTS & KITS            89

TABLE 16              IVD REAGENTS & KITS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)              90

TABLE 17              IVD REAGENTS & KITS MARKET, BY TECHNOLOGY,

2018–2025 (USD MILLION)           91

7.3          INSTRUMENTS  91

TABLE 18              IVD INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)              92

TABLE 19              IVD INSTRUMENTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)    92

TABLE 20              IVD INSTRUMENTS MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)            93

7.3.1      SEMI-AUTOMATED INSTRUMENTS          93

TABLE 21              SEMI-AUTOMATED IVD INSTRUMENTS MARKET, BY COUNTRY, 

2018–2025 (USD MILLION)           94

7.3.2      FULLY AUTOMATED INSTRUMENTS         94

TABLE 22              MAJOR LAB AUTOMATION SYSTEMS & FULLY AUTOMATED INSTRUMENTS IN THE MARKET         95

TABLE 23              FULLY AUTOMATED IVD INSTRUMENTS MARKET, BY COUNTRY, 

2018–2025 (USD MILLION)           96

7.3.3      OTHER INSTRUMENTS   96

TABLE 24              OTHER IVD INSTRUMENTS MARKET, BY COUNTRY,

2018–2025 (USD MILLION)           97

7.4          SERVICES             97

FIGURE 28           TYPES OF IN VITRO DIAGNOSTIC SERVICES           98

TABLE 25              IVD SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)               98

TABLE 26              IVD SERVICES MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)       99

7.5          DATA MANAGEMENT SOFTWARE            99

TABLE 27              KEY DATA MANAGEMENT SOFTWARE SOLUTIONS AVAILABLE IN THE MARKET   100

TABLE 28              IVD DATA MANAGEMENT SOFTWARE MARKET, BY COUNTRY, 

2018–2025 (USD MILLION)           101

TABLE 29              IVD DATA MANAGEMENT SOFTWARE MARKET, BY TECHNOLOGY, 

2018–2025 (USD MILLION)           101

8              IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY          102

8.1          INTRODUCTION                103

TABLE 30              IVD MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)           103

8.2          IMMUNOASSAY/IMMUNOCHEMISTRY  103

TABLE 31              IMMUNOASSAY/IMMUNOCHEMISTRY ANALYZERS AVAILABLE

IN THE MARKET                104

TABLE 32              IMMUNOASSAY/IMMUNOCHEMISTRY MARKET, BY TYPE,

2018–2025 (USD MILLION)           105

TABLE 33              IMMUNOASSAY/IMMUNOCHEMISTRY MARKET, BY COUNTRY, 

2018–2025 (USD MILLION)           106

8.2.1      ENZYME-LINKED IMMUNOSORBENT ASSAYS      106

TABLE 34              ELISA ANALYZERS AVAILABLE IN THE MARKET     107

TABLE 35              ENZYME-LINKED IMMUNOSORBENT ASSAYS MARKET, BY COUNTRY, 

2018–2025 (USD MILLION)           108

TABLE 36              ENZYME-LINKED IMMUNOSORBENT ASSAYS MARKET, BY TYPE, 

2018–2025 (USD MILLION)           108

8.2.1.1   Chemiluminescence immunoassays        109

TABLE 37              CHEMILUMINESCENCE IMMUNOASSAY SYSTEMS AVAILABLE IN THE MARKET     109

TABLE 38              CHEMILUMINESCENCE IMMUNOASSAYS MARKET, BY COUNTRY, 

2018–2025 (USD MILLION)           110

8.2.1.2   Fluorescence immunoassays      110

TABLE 39              FLUORESCENCE IMMUNOASSAYS MARKET, BY COUNTRY,

 2018–2025 (USD MILLION)          111

8.2.1.3   Colorimetric immunoassays        111

TABLE 40              COLORIMETRIC IMMUNOASSAYS MARKET, BY COUNTRY,

2018–2025 (USD MILLION)           112

8.2.2      RADIOIMMUNOASSAYS               112

TABLE 41              RADIOIMMUNOASSAYS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)         113

8.2.3      RAPID TESTS       113

TABLE 42              RAPID TESTS AVAILABLE IN THE MARKET               114

TABLE 43              RAPID TESTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 115

8.2.4      WESTERN BLOTTING       115

TABLE 44              WESTERN BLOTTING SYSTEMS AVAILABLE IN THE MARKET           116

TABLE 45              WESTERN BLOTTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 116

8.2.5      ENZYME-LINKED IMMUNOSPOT ASSAYS               117

TABLE 46              ELISPOT ASSAYS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)         117

8.3          CLINICAL CHEMISTRY     118

TABLE 47              CLINICAL CHEMISTRY ANALYZERS FOR HIGH- AND MID-

VOLUME LABORATORIES              118

TABLE 48              CLINICAL CHEMISTRY ANALYZERS FOR LOW-VOLUME LABORATORIES     120

TABLE 49              BLOOD GAS ANALYZERS AVAILABLE IN THE MARKET        121

TABLE 50              CLINICAL CHEMISTRY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)               122

TABLE 51              CLINICAL CHEMISTRY MARKET, BY TEST TYPE, 2018–2025 (USD MILLION)               122

8.3.1      BASIC METABOLIC PANELS          123

TABLE 52              BASIC METABOLIC PANELS MARKET, BY COUNTRY,

2018–2025 (USD MILLION)           123

8.3.2      LIVER PANELS    124

TABLE 53              LIVER PANELS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)              124

8.3.3      RENAL PROFILES               125

TABLE 54              RENAL PROFILES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)         125

8.3.4      LIPID PROFILES  126

TABLE 55              LIPID PROFILES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)            126

8.3.5      THYROID FUNCTION PANELS      127

TABLE 56              THYROID FUNCTION PANELS MARKET, BY COUNTRY,

2018–2025 (USD MILLION)           127

8.3.6      ELECTROLYTE PANELS     127

TABLE 57              ELECTROLYTE PANELS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)               128

8.3.7      SPECIALTY CHEMICAL TESTS        128

TABLE 58              SPECIALTY CHEMICAL TESTS MARKET, BY COUNTRY,

2018–2025 (USD MILLION)           129

8.4          MOLECULAR DIAGNOSTICS         129

TABLE 59              AUTOMATED MOLECULAR DIAGNOSTIC PLATFORMS AVAILABLE

IN THE MARKET                130

TABLE 60              MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY,

2018–2025 (USD MILLION)           131

TABLE 61              MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,

2018–2025 (USD MILLION)           132

8.4.1      POLYMERASE CHAIN REACTION                132

TABLE 62              PCR INSTRUMENTS AVAILABLE IN THE MARKET 133

TABLE 63              POLYMERASE CHAIN REACTION MARKET, BY COUNTRY,

2018–2025 (USD MILLION)           134

8.4.2      ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY         134

TABLE 64              ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET,

BY COUNTRY,  2018–2025 (USD MILLION)              135

8.4.3      HYBRIDIZATION                135

TABLE 65              HYBRIDIZATION MARKET, BY COUNTRY, 2018–2025 (USD MILLION)          136

8.4.4      DNA SEQUENCING & NEXT-GENERATION SEQUENCING                136

TABLE 66              NGS INSTRUMENTS AVAILABLE IN THE MARKET                137

TABLE 67              DNA SEQUENCING & NEXT-GENERATION SEQUENCING MARKET,

BY COUNTRY,  2018–2025 (USD MILLION)              138

8.4.5      MICROARRAYS  138

TABLE 68              MICROARRAYS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)            139

8.4.6      OTHER MDX TECHNOLOGIES       140

TABLE 69              OTHER MOLECULAR DIAGNOSTIC TECHNOLOGIES MARKET, BY COUNTRY,  2018–2025 (USD MILLION)     140

8.5          HEMATOLOGY   141

TABLE 70              HEMATOLOGY ANALYZERS AVAILABLE IN THE MARKET  141

TABLE 71              HEMATOLOGY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)             143

8.6          MICROBIOLOGY               143

TABLE 72              MICROBIOLOGY INSTRUMENTS AVAILABLE IN THE MARKET        144

TABLE 73              MICROBIOLOGY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)         145

8.7          COAGULATION & HEMOSTASIS 146

TABLE 74              COAGULATION ANALYZERS AVAILABLE IN THE MARKET 146

TABLE 75              POINT-OF-CARE/SELF-MONITORING COAGULATION ANALYZERS  AVAILABLE IN THE MARKET     148

TABLE 76              COAGULATION & HEMOSTASIS MARKET, BY COUNTRY,

2018–2025 (USD MILLION)           148

8.8          URINALYSIS        149

TABLE 77              URINALYSIS INSTRUMENTS AVAILABLE IN THE MARKET 149

TABLE 78              URINALYSIS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)  150

8.9          OTHER TECHNOLOGIES  150

TABLE 79              BLOOD GLUCOSE TESTING SYSTEMS AVAILABLE IN THE MARKET                151

TABLE 80              TISSUE PROCESSORS, EMBEDDERS, MICROTOMES, AND STAINERS  AVAILABLE IN THE MARKET  151

TABLE 81              OTHER TECHNOLOGIES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)            153

9              IN VITRO DIAGNOSTICS MARKET, BY APPLICATION          154

9.1          INTRODUCTION                155

TABLE 82              IVD MARKET, BY APPLICATION, 2018–2025 (USD MILLION)           155

9.2          INFECTIOUS DISEASES   155

TABLE 83              IVD MARKET FOR INFECTIOUS DISEASES, BY COUNTRY,

2018–2025 (USD MILLION)           156

9.3          DIABETES             156

TABLE 84              GLOBAL DIABETIC PATIENT POPULATION, 2019 VS. 2030 (MILLION)          157

TABLE 85              IVD MARKET FOR DIABETES, BY COUNTRY, 2018–2025 (USD MILLION)     158

9.4          ONCOLOGY        158

TABLE 86              IVD MARKET FOR ONCOLOGY, BY COUNTRY, 2018–2025 (USD MILLION) 159

9.5          CARDIOLOGY     160

TABLE 87              IVD MARKET FOR CARDIOLOGY, BY COUNTRY, 2018–2025 (USD MILLION)             160

9.6          DRUG TESTING/PHARMACOGENOMICS                161

TABLE 88              IVD MARKET FOR DRUG TESTING/PHARMACOGENOMICS, BY COUNTRY,  2018–2025 (USD MILLION)       161

9.7          HIV/AIDS             162

TABLE 89              IVD MARKET FOR HIV/AIDS, BY COUNTRY, 2018–2025 (USD MILLION)     162

9.8          AUTOIMMUNE DISEASES             163

TABLE 90              IVD MARKET FOR AUTOIMMUNE DISEASES, BY COUNTRY,

2018–2025 (USD MILLION)           164

9.9          NEPHROLOGY    164

TABLE 91              IVD MARKET FOR NEPHROLOGY, BY COUNTRY, 2018–2025 (USD MILLION)            165

9.10        OTHER APPLICATIONS   165

TABLE 92              IVD MARKET FOR OTHER APPLICATIONS, BY COUNTRY,

2018–2025 (USD MILLION)           166

10           IN VITRO DIAGNOSTICS MARKET, BY END USER 167

10.1        INTRODUCTION                168

TABLE 93              IVD MARKET, BY END USER, 2018–2025 (USD MILLION)  168

10.2        HOSPITAL LABORATORIES            168

TABLE 94              IVD MARKET FOR HOSPITAL LABORATORIES, BY COUNTRY,

2018–2025 (USD MILLION)           169

 

10.3        CLINICAL LABORATORIES              169

TABLE 95              IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE,

2018–2025 (USD MILLION)           170

TABLE 96              IVD MARKET FOR CLINICAL LABORATORIES, BY COUNTRY,

2018–2025 (USD MILLION)           170

10.3.1    LARGE/REFERENCE LABORATORIES          171

TABLE 97              LARGE/REFERENCE LABORATORIES MARKET, BY COUNTRY,

2018–2025 (USD MILLION)           171

10.3.2    MEDIUM-SIZED LABORATORIES                172

TABLE 98              MEDIUM-SIZED LABORATORIES MARKET, BY COUNTRY,

2018–2025 (USD MILLION)           172

10.3.3    SMALL LABORATORIES  172

TABLE 99              SMALL LABORATORIES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)            173

10.4        POINT-OF-CARE TESTING             173

TABLE 100            IVD MARKET FOR POC TESTING, BY COUNTRY, 2018–2025 (USD MILLION)             174

10.5        PATIENT SELF-TESTING  174

TABLE 101            IVD MARKET FOR PATIENT SELF-TESTING, BY COUNTRY,

2018–2025 (USD MILLION)           175

10.6        ACADEMIC INSTITUTES 175

TABLE 102            IVD MARKET FOR ACADEMIC INSTITUTES, BY COUNTRY,

2018–2025 (USD MILLION)           176

10.7        OTHER END USERS           176

TABLE 103            IVD MARKET FOR OTHER END USERS, BY COUNTRY,

2018–2025 (USD MILLION)           177

11           IN VITRO DIAGNOSTICS MARKET, BY REGION     178

11.1        INTRODUCTION                179

TABLE 104            IVD MARKET, BY REGION, 2018–2025 (USD MILLION)      179

11.2        NORTH AMERICA             179

FIGURE 29           NORTH AMERICA: IVD MARKET SNAPSHOT          180

TABLE 105            NORTH AMERICA: IVD MARKET, BY COUNTRY, 2018–2025 (USD MILLION)             180

TABLE 106            NORTH AMERICA: IVD MARKET, BY PRODUCT & SERVICE,

2018–2025 (USD MILLION)           181

TABLE 107            NORTH AMERICA: IVD INSTRUMENTS MARKET, BY TYPE,

2018–2025 (USD MILLION)           181

TABLE 108            NORTH AMERICA: IVD MARKET, BY APPLICATION,

2018–2025 (USD MILLION)           181

TABLE 109            NORTH AMERICA: IVD MARKET, BY TECHNOLOGY,

2018–2025 (USD MILLION)           182

TABLE 110            NORTH AMERICA: IVD MARKET, BY END USER, 2018–2025 (USD MILLION)             182

TABLE 111            NORTH AMERICA: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE,  2018–2025 (USD MILLION)          182

11.2.1    US          183

TABLE 112            US: IVD MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)     183

TABLE 113            US: IVD INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)      183

TABLE 114            US: IVD MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)   184

TABLE 115            US: IVD MARKET, BY APPLICATION, 2018–2025 (USD MILLION)   184

TABLE 116            US: IVD MARKET, BY END USER, 2018–2025 (USD MILLION)          185

TABLE 117            US: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE, 

2018–2025 (USD MILLION)           185

11.2.2    CANADA              185

TABLE 118            CANADA: IVD MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)        186

TABLE 119            CANADA: IVD INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)          186

TABLE 120            CANADA: IVD MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)      186

TABLE 121            CANADA: IVD MARKET, BY APPLICATION, 2018–2025 (USD MILLION)       187

TABLE 122            CANADA: IVD MARKET, BY END USER, 2018–2025 (USD MILLION)              187

TABLE 123            CANADA: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE, 

2018–2025 (USD MILLION)           187

11.3        EUROPE               188

FIGURE 30           EUROPE: IVD MARKET SNAPSHOT            188

TABLE 124            EUROPE: IVD MARKET, BY COUNTRY, 2018–2025 (USD MILLION)                189

TABLE 125            EUROPE: IVD MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)          189

TABLE 126            EUROPE: IVD INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)           189

TABLE 127            EUROPE: IVD MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)        190

TABLE 128            EUROPE: IVD MARKET, BY APPLICATION, 2018–2025 (USD MILLION)        190

TABLE 129            EUROPE: IVD MARKET, BY END USER, 2018–2025 (USD MILLION)               191

TABLE 130            EUROPE: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE, 

2018–2025 (USD MILLION)           191

11.3.1    GERMANY           191

TABLE 131            GERMANY: IVD MARKET, BY PRODUCT & SERVICE,

2018–2025 (USD MILLION)           192

TABLE 132            GERMANY: IVD INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)      192

TABLE 133            GERMANY: IVD MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)   192

TABLE 134            GERMANY: IVD MARKET, BY APPLICATION, 2018–2025 (USD MILLION)   193

TABLE 135            GERMANY: IVD MARKET, BY END USER, 2018–2025 (USD MILLION)           193

TABLE 136            GERMANY: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE, 

2018–2025 (USD MILLION)           193

11.3.2    FRANCE                194

TABLE 137            FRANCE: IVD MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)          194

TABLE 138            FRANCE: IVD INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)           194

TABLE 139            FRANCE: IVD MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)        195

TABLE 140            FRANCE: IVD MARKET, BY APPLICATION, 2018–2025 (USD MILLION)        195

TABLE 141            FRANCE: IVD MARKET, BY END USER, 2018–2025 (USD MILLION)                196

TABLE 142            FRANCE: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE, 

2018–2025 (USD MILLION)           196

11.3.3    UK          196

TABLE 143            UK: IVD MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)    197

TABLE 144            UK: IVD INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)      197

TABLE 145            UK: IVD MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)  197

TABLE 146            UK: IVD MARKET, BY APPLICATION, 2018–2025 (USD MILLION)   198

TABLE 147            UK: IVD MARKET, BY END USER, 2018–2025 (USD MILLION)          198

TABLE 148            UK: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE, 

2018–2025 (USD MILLION)           198

11.3.4    ITALY     199

TABLE 149            ITALY: IVD MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)               199

TABLE 150            ITALY: IVD INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 199

TABLE 151            ITALY: IVD MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)             199

TABLE 152            ITALY: IVD MARKET, BY APPLICATION, 2018–2025 (USD MILLION)              200

TABLE 153            ITALY: IVD MARKET, BY END USER, 2018–2025 (USD MILLION)     200

TABLE 154            ITALY: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE, 

2018–2025 (USD MILLION)           200

11.3.5    SPAIN   201

TABLE 155            SPAIN: IVD MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)              201

TABLE 156            SPAIN: IVD INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)               201

TABLE 157            SPAIN: IVD MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)            202

TABLE 158            SPAIN: IVD MARKET, BY APPLICATION, 2018–2025 (USD MILLION)            202

TABLE 159            SPAIN: IVD MARKET, BY END USER, 2018–2025 (USD MILLION)   203

TABLE 160            SPAIN: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE, 

2018–2025 (USD MILLION)           203

11.3.6    RUSSIA 203

TABLE 161            RUSSIA: IVD MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)           204

TABLE 162            RUSSIA: IVD INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)             204

TABLE 163            RUSSIA: IVD MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)         204

TABLE 164            RUSSIA: IVD MARKET, BY APPLICATION, 2018–2025 (USD MILLION)          205

TABLE 165            RUSSIA: IVD MARKET, BY END USER, 2018–2025 (USD MILLION) 205

TABLE 166            RUSSIA: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE, 

2018–2025 (USD MILLION)           205

11.3.7    REST OF EUROPE              206

TABLE 167            ROE: IVD MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)  206

TABLE 168            ROE: IVD INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)   206

TABLE 169            ROE: IVD MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)                207

TABLE 170            ROE: IVD MARKET, BY APPLICATION, 2018–2025 (USD MILLION)                207

TABLE 171            ROE: IVD MARKET, BY END USER, 2018–2025 (USD MILLION)        208

TABLE 172            ROE: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE, 

2018–2025 (USD MILLION)           208

11.4        ASIA PACIFIC     208

FIGURE 31           ASIA PACIFIC: IVD MARKET SNAPSHOT  209

TABLE 173            ASIA PACIFIC: IVD MARKET, BY COUNTRY, 2018–2025 (USD MILLION)      209

TABLE 174            ASIA PACIFIC: IVD MARKET, BY PRODUCT & SERVICE,

2018–2025 (USD MILLION)           210

TABLE 175            ASIA PACIFIC: IVD INSTRUMENTS MARKET, BY TYPE,

2018–2025 (USD MILLION)           210

TABLE 176            ASIA PACIFIC: IVD MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)              210

TABLE 177            ASIA PACIFIC: IVD MARKET, BY APPLICATION, 2018–2025 (USD MILLION)              211

TABLE 178            ASIA PACIFIC: IVD MARKET, BY END USER, 2018–2025 (USD MILLION)     211

TABLE 179            ASIA PACIFIC: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE, 

2018–2025 (USD MILLION)           211

11.4.1    JAPAN  212

TABLE 180            JAPAN: IVD MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)             212

TABLE 181            JAPAN: IVD INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)              212

TABLE 182            JAPAN: IVD MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)           213

TABLE 183            JAPAN: IVD MARKET, BY APPLICATION, 2018–2025 (USD MILLION)           213

TABLE 184            JAPAN: IVD MARKET, BY END USER, 2018–2025 (USD MILLION)  214

TABLE 185            JAPAN: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE, 

2018–2025 (USD MILLION)           214

11.4.2    CHINA   214

TABLE 186            CHINA: IVD MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)             215

TABLE 187            CHINA: IVD INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)              215

TABLE 188            CHINA: IVD MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)           215

TABLE 189            CHINA: IVD MARKET, BY APPLICATION, 2018–2025 (USD MILLION)           216

TABLE 190            CHINA: IVD MARKET, BY END USER, 2018–2025 (USD MILLION)   216

TABLE 191            CHINA: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE, 

2018–2025 (USD MILLION)           216

11.4.3    INDIA    217

TABLE 192            INDIA: IVD MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)              217

TABLE 193            INDIA: IVD INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)                218

TABLE 194            INDIA: IVD MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)            218

TABLE 195            INDIA: IVD MARKET, BY APPLICATION, 2018–2025 (USD MILLION)             218

TABLE 196            INDIA: IVD MARKET, BY END USER, 2018–2025 (USD MILLION)    219

TABLE 197            INDIA: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE, 

2018–2025 (USD MILLION)           219

11.4.4    SOUTH KOREA   219

TABLE 198            SOUTH KOREA: IVD MARKET, BY PRODUCT & SERVICE,

2018–2025 (USD MILLION)           220

TABLE 199            SOUTH KOREA: IVD INSTRUMENTS MARKET, BY TYPE,

2018–2025 (USD MILLION)           220

TABLE 200            SOUTH KOREA: IVD MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)           220

TABLE 201            SOUTH KOREA: IVD MARKET, BY APPLICATION, 2018–2025 (USD MILLION)           221

TABLE 202            SOUTH KOREA: IVD MARKET, BY END USER, 2018–2025 (USD MILLION)   221

TABLE 203            SOUTH KOREA: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE, 

2018–2025 (USD MILLION)           221

11.4.5    INDONESIA         222

TABLE 204            INDONESIA: IVD MARKET, BY PRODUCT & SERVICE,

2018–2025 (USD MILLION)           222

TABLE 205            INDONESIA: IVD INSTRUMENTS MARKET, BY TYPE,

2018–2025 (USD MILLION)           222

TABLE 206            INDONESIA: IVD MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION) 223

TABLE 207            INDONESIA: IVD MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 223

TABLE 208            INDONESIA: IVD MARKET, BY END USER, 2018–2025 (USD MILLION)         224

TABLE 209            INDONESIA: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE, 

2018–2025 (USD MILLION)           224

11.4.6    REST OF ASIA PACIFIC    224

TABLE 210            ROAPAC: IVD MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)         224

TABLE 211            ROAPAC: IVD INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)          225

TABLE 212            ROAPAC: IVD MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)       225

TABLE 213            ROAPAC: IVD MARKET, BY APPLICATION, 2018–2025 (USD MILLION)       225

TABLE 214            ROAPAC: IVD MARKET, BY END USER, 2018–2025 (USD MILLION)               226

TABLE 215            ROAPAC: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE, 

2018–2025 (USD MILLION)           226

11.5        LATIN AMERICA                226

TABLE 216            LATIN AMERICA: IVD MARKET, BY COUNTRY, 2018–2025 (USD MILLION)                227

TABLE 217            LATIN AMERICA: IVD MARKET, BY PRODUCT & SERVICE,

2018–2025 (USD MILLION)           227

TABLE 218            LATIN AMERICA: IVD INSTRUMENTS MARKET, BY TYPE,

2018–2025 (USD MILLION)           227

TABLE 219            LATIN AMERICA: IVD MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)        228

TABLE 220            LATIN AMERICA: IVD MARKET, BY APPLICATION, 2018–2025 (USD MILLION)        228

TABLE 221            LATIN AMERICA: IVD MARKET, BY END USER, 2018–2025 (USD MILLION)                229

TABLE 222            LATIN AMERICA: IVD MARKET FOR CLINICAL LABORATORIES,

BY TYPE,  2018–2025 (USD MILLION)        229

11.5.1    BRAZIL  229

TABLE 223            BRAZIL: IVD MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)            230

TABLE 224            BRAZIL: IVD INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)              230

TABLE 225            BRAZIL: IVD MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)          230

TABLE 226            BRAZIL: IVD MARKET, BY APPLICATION, 2018–2025 (USD MILLION)           231

TABLE 227            BRAZIL: IVD MARKET, BY END USER, 2018–2025 (USD MILLION)  231

TABLE 228            BRAZIL: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE, 

2018–2025 (USD MILLION)           231

11.5.2    MEXICO               232

TABLE 229            MEXICO: IVD MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)          232

TABLE 230            MEXICO: IVD INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)           232

TABLE 231            MEXICO: IVD MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)        233

TABLE 232            MEXICO: IVD MARKET, BY APPLICATION, 2018–2025 (USD MILLION)        233

TABLE 233            MEXICO: IVD MARKET, BY END USER, 2018–2025 (USD MILLION)               234

TABLE 234            MEXICO: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE, 

2018–2025 (USD MILLION)           234

11.5.3    REST OF LATIN AMERICA              234

TABLE 235            ROLA: IVD MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)               234

TABLE 236            ROLA: IVD INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 235

TABLE 237            ROLA: IVD MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)             235

TABLE 238            ROLA: IVD MARKET, BY APPLICATION, 2018–2025 (USD MILLION)              235

TABLE 239            ROLA: IVD MARKET, BY END USER, 2018–2025 (USD MILLION)     236

TABLE 240            ROLA: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE, 

2018–2025 (USD MILLION)           236

11.6        MIDDLE EAST & AFRICA 236

TABLE 241            MIDDLE EAST & AFRICA: IVD MARKET, BY COUNTRY,

2018–2025 (USD MILLION)           236

TABLE 242            MIDDLE EAST & AFRICA: IVD MARKET, BY PRODUCT & SERVICE, 

2018–2025 (USD MILLION)           237

TABLE 243            MIDDLE EAST & AFRICA: IVD INSTRUMENTS MARKET, BY TYPE, 

2018–2025 (USD MILLION)           237

TABLE 244            MIDDLE EAST & AFRICA: IVD MARKET, BY TECHNOLOGY,

2018–2025 (USD MILLION)           237

TABLE 245            MIDDLE EAST & AFRICA: IVD MARKET, BY APPLICATION,

2018–2025 (USD MILLION)           238

TABLE 246            MIDDLE EAST & AFRICA: IVD MARKET, BY END USER,

2018–2025 (USD MILLION)           238

TABLE 247            MIDDLE EAST & AFRICA: IVD MARKET FOR CLINICAL LABORATORIES,

BY TYPE,  2018–2025 (USD MILLION)        238

11.6.1    SAUDI ARABIA  239

TABLE 248            SAUDI ARABIA: IVD MARKET, BY PRODUCT & SERVICE,

2018–2025 (USD MILLION)           239

TABLE 249            SAUDI ARABIA: IVD INSTRUMENTS MARKET, BY TYPE,

 2018–2025 (USD MILLION)          239

TABLE 250            SAUDI ARABIA: IVD MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)           240

TABLE 251            SAUDI ARABIA: IVD MARKET, BY END USER, 2018–2025 (USD MILLION)  240

TABLE 252            SAUDI ARABIA: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE, 

2018–2025 (USD MILLION)           241

11.6.2    REST OF MIDDLE EAST & AFRICA (ROMEA)           241

TABLE 253            ROMEA: IVD MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)           241

TABLE 254            ROMEA: IVD INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)            241

TABLE 255            ROMEA: IVD MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)         242

TABLE 256            ROMEA: IVD MARKET, BY APPLICATION, 2018–2025 (USD MILLION)         242

TABLE 257            ROMEA: IVD MARKET, BY END USER, 2018–2025 (USD MILLION)                243

TABLE 258            ROMEA: IVD MARKET FOR CLINICAL LABORATORIES, BY TYPE, 

2018–2025 (USD MILLION)           243

12           COMPETITIVE LANDSCAPE           244

12.1        INTRODUCTION                244

FIGURE 32           KEY DEVELOPMENTS IN THE IVD MARKET             244

12.2        COMPETITIVE EVALUATION MATRIX       245

12.2.1    STARS   245

12.2.2    EMERGING LEADERS      245

12.2.3    PERVASIVE PLAYERS       245

12.2.4    PARTICIPANTS  245

FIGURE 33           IVD MARKET: COMPETITIVE LEADERSHIP MAPPING (2019)           246

 

12.3        MARKET SHARE ANALYSIS            246

FIGURE 34           GLOBAL IN VITRO DIAGNOSTICS MARKET SHARE ANALYSIS, 

BY KEY PLAYER (2019)     247

12.3.1    MARKET SHARE ANALYSIS, BY TECHNOLOGY       248

12.3.1.1                Clinical chemistry             248

FIGURE 35           GLOBAL CLINICAL CHEMISTRY MARKET SHARE ANALYSIS,  BY KEY PLAYER (2019)                248

12.3.1.2                Immunochemistry/immunoassay analyzers         248

FIGURE 36           GLOBAL IMMUNOASSAYS MARKET SHARE ANALYSIS, BY KEY PLAYER (2019)         249

12.3.1.3                Clinical microbiology systems      249

FIGURE 37           GLOBAL MICROBIOLOGY MARKET SHARE ANALYSIS, BY KEY PLAYER (2019)           249

12.3.1.4                Molecular diagnostics    250

FIGURE 38           GLOBAL MOLECULAR DIAGNOSTICS MARKET SHARE ANALYSIS,  

BY KEY PLAYER (2019)     250

12.3.1.5                Hematology       250

FIGURE 39           GLOBAL HEMATOLOGY MARKET SHARE ANALYSIS, BY KEY PLAYER (2019)               251

12.3.1.6                Clinical coagulation analyzers      251

FIGURE 40           GLOBAL CLINICAL COAGULATION ANALYZERS MARKET SHARE ANALYSIS, 

BY KEY PLAYER (2019)     251

12.4        COMPETITIVE SITUATION AND TRENDS 252

12.4.1    PRODUCT LAUNCHES & APPROVALS       252

TABLE 259            PRODUCT LAUNCHES & APPROVALS       252

12.4.2    AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 252

TABLE 260            AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 253

12.4.3    ACQUISITIONS  253

TABLE 261            ACQUISITIONS  253

12.4.4    EXPANSIONS     254

TABLE 262            EXPANSIONS     254

13           COMPANY PROFILES      255

(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*

13.1        ROCHE DIAGNOSTICS     255

FIGURE 41           F. HOFFMANN-LA ROCHE: COMPANY SNAPSHOT (2019)                255

13.2        DANAHER CORPORATION            262

FIGURE 42           DANAHER CORPORATION: COMPANY SNAPSHOT (2019)               262

13.3        ABBOTT LABORATORIES, INC.     272

FIGURE 43           ABBOTT LABORATORIES: COMPANY SNAPSHOT (2019)   272

13.4        SIEMENS HEALTHINEERS               279

FIGURE 44           SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2019)  279

13.5        SYSMEX CORPORATION                286

FIGURE 45           SYSMEX CORPORATION: COMPANY SNAPSHOT (2019)   286

13.6        THERMO FISHER SCIENTIFIC        291

FIGURE 46           THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2016)           291

13.7        BECTON, DICKINSON AND COMPANY     302

FIGURE 47           BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2019)        302

13.8        BIOMÉRIEUX SA               307

FIGURE 48           BIOMÉRIEUX SA: COMPANY SNAPSHOT (2019)  307

13.9        BIO-RAD LABORATORIES, INC.   312

FIGURE 49           BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2019) 312

13.10     JOHNSON & JOHNSON  318

FIGURE 50           JOHNSON & JOHNSON: COMPANY SNAPSHOT (2019)     318

13.11     AGILENT TECHNOLOGIES              320

FIGURE 51           AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2019) 320

13.12     QIAGEN               325

FIGURE 52           QIAGEN: COMPANY SNAPSHOT (2019)  325

13.13     DIASORIN            331

FIGURE 53           DIASORIN: COMPANY SNAPSHOT (2019)               331

13.14     ORTHO CLINICAL DIAGNOSTICS (A PART OF CARLYLE GROUP)     341

13.15     SPEEDX DIAGNOSTICS   343

13.16     GENSPEED BIOTECH GMBH         344

13.17     GENOMEME      345

13.18     ACCELERATE DIAGNOSTICS, INC.              346

13.19     MSDX    347

13.20     CARIS LIFE SCIENCES, INC.            347

*Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.

14           APPENDIX           348

14.1        DISCUSSION GUIDE        349

14.2        KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL   355

14.3        AVAILABLE CUSTOMIZATIONS   357

14.4        RELATED REPORTS           358

14.5        AUTHOR DETAILS             359

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Lateral Flow Assay Components Market by Type, Application Type (Clinical Testing (Infectious, Cardiac Marker Test) Veterinary, Food Safety), Technique...

Publisher:        MarketsandMarkets

# of Pages:        224

Rating: 

1 User License $4,950

Publication Date:  April, 2022

Price:       $4,950 / User License




1 INTRODUCTION 33
1.1 OBJECTIVES OF THE STUDY 33
1.2 MARKET DEFINITION 33
1.2.1 CATEGORY-WISE INCLUSIONS AND EXCLUSIONS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 33
1.3 MARKET SCOPE 34
1.3.1 MARKETS COVERED 34
FIGURE 1 LATERAL FLOW ASSAY COMPONENTS MARKET SEGMENTATION 34
1.3.2 YEARS CONSIDERED FOR THE STUDY 35
1.4 CURRENCY 35
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 35
1.5 STAKEHOLDERS 35
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH APPROACH 36
FIGURE 2 RESEARCH DESIGN 36
2.1.1 SECONDARY DATA 36
2.1.1.1 Key data from secondary sources 37
2.1.2 PRIMARY DATA 38
2.1.2.1 Primary sources 38
2.1.2.2 Key data from primary sources 39
2.1.2.3 Breakdown of primaries 39
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE):
BY COMPANY TYPE, DESIGNATION, AND REGION 39
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 40
2.2 MARKET SIZE ESTIMATION 40
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2021) 41
FIGURE 6 SUPPLY-SIDE ANALYSIS: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 42
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 44
FIGURE 7 DATA TRIANGULATION METHODOLOGY 45
2.4 KEY INDUSTRY INSIGHTS 46
2.5 LIMITATIONS 46
2.5.1 METHODOLOGY-RELATED LIMITATIONS 46
2.6 RISK ASSESSMENT 47
2.7 ASSUMPTIONS FOR THE STUDY 47
 
3 EXECUTIVE SUMMARY 48
FIGURE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2022 VS. 2027 (USD MILLION) 48
FIGURE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2022 VS. 2027 (USD MILLION) 49
FIGURE 10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION) 50
FIGURE 11 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2022 VS. 2027 (USD MILLION) 51
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 52
4 PREMIUM INSIGHTS 53
4.1 LATERAL FLOW ASSAY COMPONENTS MARKET OVERVIEW 53
FIGURE 13 RISING NUMBER OF LOCAL MANUFACTURERS FOR COMPONENTS IS DRIVING THE GROWTH OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 53
4.2 REGIONAL MIX: LATERAL FLOW ASSAY COMPONENTS MARKET 54
FIGURE 14 APAC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 54
4.3 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE AND COUNTRY 55
FIGURE 15 MEMBRANES ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2021 55
4.4 LATERAL FLOW ASSAY COMPONENTS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 56
4.5 LATERAL FLOW ASSAY COMPONENTS MARKET: DEVELOPED VS. DEVELOPING COUNTRIES 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS: IMPACT ANALYSIS 57
5.2.1 DRIVERS 58
5.2.1.1 Growing demand for lateral flow assay kits due
to the COVID-19 pandemic 58
5.2.1.2 Growing usage of home-based lateral flow assay devices 58
5.2.1.3 Growing demand for point-of-care testing 58
5.2.1.4 Increasing public-private investments to develop lateral flow assays 59
5.2.2 RESTRAINTS 59
5.2.2.1 Availability of alternative diagnostic technologies 59
5.2.3 OPPORTUNITIES 59
5.2.3.1 Evolving applications of lateral flow assays 59
5.2.4 CHALLENGES 60
5.2.4.1 Requirement of specialized storage and shipping facilities for membranes 60
5.3 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES (YC-YCC) IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
FIGURE 16 YC–YCC SHIFT IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 61
5.5 AVERAGE SELLING PRICE TREND 61
TABLE 2 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAY COMPONENTS,
BY REGION, 2021 (USD) 61
5.6 ECOSYSTEM MARKET MAP 62
FIGURE 17 ECOSYSTEM: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 62
5.7 PATENT ANALYSIS 63
5.7.1 PATENT PUBLICATION TRENDS FOR LATERAL FLOW ASSAYS 63
FIGURE 18 GLOBAL PATENT PUBLICATION TRENDS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2016–2021 64
5.7.2 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 64
FIGURE 19 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR LATERAL FLOW ASSAYS COMPONENTS, 2016–2021 64
5.8 VALUE CHAIN ANALYSIS 65
5.9 REGULATORY LANDSCAPE 66
TABLE 3 REGULATORY STANDARDS/APPROVALS REQUIRED FOR LATERAL FLOW IMMUNOASSAY PRODUCTS, BY COUNTRY/REGION 66
5.9.1 NORTH AMERICA 66
5.9.2 EUROPE 67
5.9.3 ASIA PACIFIC 67
5.9.3.1 India 67
5.9.3.2 China 67
5.9.3.3 Japan 68
5.10 TECHNOLOGY ANALYSIS 69
5.10.1 KEY TECHNOLOGY: LATERAL FLOW ASSAYS 69
5.11 KEY CONFERENCES & EVENTS DURING 2021–2023 69
TABLE 4 LATERAL FLOW ASSAY COMPONENTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS 69
5.12 KEY STAKEHOLDERS & BUYING CRITERIA 70
5.12.1 KEY STAKEHOLDERS IN THE BUYING PROCESS 70
FIGURE 20 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
TABLE 5 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
5.12.2 BUYING CRITERIA 71
FIGURE 21 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
TABLE 6 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
5.13 PORTER’S FIVE FORCES ANALYSIS 72
TABLE 7 LATERAL FLOW ASSAY COMPONENTS MARKET:
PORTER’S FIVE FORCES ANALYSIS 72
5.13.1 THREAT FROM NEW ENTRANTS 72
5.13.2 THREAT FROM SUBSTITUTES 72
5.13.3 BARGAINING POWER OF BUYERS 73
5.13.4 BARGAINING POWER OF SUPPLIERS 73
5.13.5 INTENSITY OF COMPETITIVE RIVALRY 73
6 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE 74
6.1 INTRODUCTION 75
TABLE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 75
6.2 MEMBRANES 75
TABLE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE,
2020–2027 (USD MILLION) 76
TABLE 10 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 76
6.2.1 NITROCELLULOSE MEMBRANES 77
6.2.1.1 Advantages of nitrocellulose membranes such as high protein-binding affinity and compatibility with a wide range of detection methods to drive market growth 77
TABLE 11 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES, BY COUNTRY, 2020–2027 (USD MILLION) 77
TABLE 12 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (1 X 1 M SHEETS), BY REGION, 2020–2027 (IN THOUSANDS) 78
TABLE 13 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (20 MM X 1 M ROLLS), BY REGION, 2020–2027 (IN MILLIONS) 78
6.2.2 OTHER MEMBRANES 78
TABLE 14 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 79
6.3 PADS 80
TABLE 15 EXAMPLES OF DIFFERENT MATERIALS USED IN MANUFACTURING LATERAL FLOW ASSAY PADS 80
TABLE 16 LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 80
TABLE 17 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PADS, BY COUNTRY, 2020–2027 (USD MILLION) 81
6.3.1 SAMPLE PADS 81
6.3.1.1 Ability to promote even and controlled distribution of samples to drive market growth 81
TABLE 18 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SAMPLE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 82
6.3.2 CONJUGATE PADS 82
6.3.2.1 Conjugate pads play an important role in controlling the performance of lateral flow immunoassays 82
TABLE 19 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CONJUGATE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 83
6.3.3 ABSORBENT PADS 84
6.3.3.1 Absorbent pads prevent backflow—a key factor driving market growth 84
TABLE 20 LATERAL FLOW ASSAY COMPONENTS MARKET FOR ABSORBENT PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 84
6.4 OTHER COMPONENTS 84
TABLE 21 OTHER LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 85
7 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION 86
7.1 INTRODUCTION 87
TABLE 22 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 87
7.2 CLINICAL TESTING 87
TABLE 23 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 88
TABLE 24 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS,
BY COUNTRY, 2020–2027 (USD MILLION) 88
7.2.1 INFECTIOUS DISEASE TESTING 89
7.2.1.1 Rising demand for infectious disease testing in emerging markets to drive market growth 89
TABLE 25 LATERAL FLOW ASSAY COMPONENTS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 89
7.2.2 PREGNANCY & FERTILITY TESTING 90
7.2.2.1 Growing infertility levels due to changing lifestyles—a key factor driving market growth 90
TABLE 26 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 90
7.2.3 CARDIAC MARKER TESTING 91
7.2.3.1 Rising prevalence of cardiovascular diseases and growing government support to drive growth in this market segment 91
TABLE 27 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 92
7.2.4 CHOLESTEROL TESTING/LIPID PROFILING 92
7.2.4.1 Growing prevalence of obesity and CVD—
a key factor driving market growth 92
TABLE 28 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CHOLESTEROL TESTING/LIPID PROFILING, BY COUNTRY, 2020–2027 (USD MILLION) 93
7.2.5 DRUGS-OF-ABUSE TESTING 93
7.2.5.1 Technological advancements and a growing focus on workplace
drug testing are driving market growth 93
TABLE 29 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUGS-OF-ABUSE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 94
7.2.6 OTHER CLINICAL TESTING APPLICATIONS 94
TABLE 30 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER CLINICAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 95
7.3 VETERINARY DIAGNOSTICS 95
7.3.1 INFECTIOUS DISEASE OUTBREAKS (PARTICULARLY IN LARGE LIVESTOCK ANIMALS) TO DRIVE MARKET GROWTH 95
TABLE 31 LATERAL FLOW ASSAY COMPONENTS MARKET FOR VETERINARY DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 96
7.4 FOOD SAFETY & ENVIRONMENTAL TESTING 96
7.4.1 HIGH SENSITIVITY AND EASE OF USE ARE KEY FACTORS DRIVING THE DEMAND FOR LATERAL FLOW ASSAYS FOR FOOD SAFETY TESTING 96
TABLE 32 LATERAL FLOW ASSAY COMPONENTS MARKET FOR FOOD SAFETY & ENVIRONMENTAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 97
7.5 DRUG DEVELOPMENT & QUALITY TESTING 97
7.5.1 INCREASING FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE TO DRIVE MARKET GROWTH IN THE COMING YEARS 97
TABLE 33 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 98
8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE 99
8.1 INTRODUCTION 100
TABLE 34 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 100
8.2 SANDWICH ASSAYS 100
8.2.1 SANDWICH ASSAYS PROVIDE HIGHER LEVELS OF ASSAY SENSITIVITY AND SPECIFICITY THAN OTHER ASSAY TECHNIQUES—A KEY FACTOR DRIVING GROWTH IN THIS MARKET SEGMENT 100
TABLE 35 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SANDWICH ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 101
8.3 COMPETITIVE ASSAYS 101
8.3.1 REDUCED SELECTIVITY AND SENSITIVITY OF COMPETITIVE ASSAYS IN RELATION TO SANDWICH ASSAYS COULD HAMPER MARKET GROWTH 101
TABLE 36 LATERAL FLOW ASSAY COMPONENTS MARKET FOR COMPETITIVE ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 102
8.4 MULTIPLEX DETECTION ASSAYS 102
8.4.1 INCREASING ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO DRIVE MARKET GROWTH 102
TABLE 37 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2020–2027 (USD MILLION) 103
9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER 104
9.1 INTRODUCTION 105
TABLE 38 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 105
9.2 MEDICAL DEVICE MANUFACTURING COMPANIES 105
9.2.1 INCREASING USE OF POC TESTS IS DRIVING THE ADOPTION OF LATERAL FLOW ASSAY COMPONENTS AMONG MEDICAL DEVICE MANUFACTURING COMPANIES 105
TABLE 39 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE MANUFACTURING COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 106
9.3 MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES 106
9.3.1 GROWING INCLINATION TOWARD FAST AND EARLY DIAGNOSIS, ESPECIALLY IN RELATION TO THE CURRENT COVID-19 SCENARIO, WILL DRIVE MARKET GROWTH 106
TABLE 40 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES, BY COUNTRY,
2020–2027 (USD MILLION) 107
 
10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION 108
10.1 INTRODUCTION 109
FIGURE 22 CHINA TO REGISTER THE HIGHEST GROWTH IN THE LATERAL FLOW ASSAY COMPONENTS MARKET DURING THE FORECAST PERIOD 109
TABLE 41 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION,
2020–2027 (USD MILLION) 110
10.2 NORTH AMERICA 110
TABLE 42 NORTH AMERICA: MACROECONOMIC INDICATORS 110
FIGURE 23 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 111
TABLE 43 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 112
TABLE 44 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 112
TABLE 45 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 112
TABLE 46 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 113
TABLE 47 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 113
TABLE 48 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 114
TABLE 49 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 114
TABLE 50 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 115
10.2.1 US 115
10.2.1.1 Increasing R&D investments and venture capital funding from both large and small firms towards the development of lateral flow assay diagnostics to drive market growth in the US 115
TABLE 51 US: MACROECONOMIC INDICATORS 116
TABLE 52 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 116
TABLE 53 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 116
TABLE 54 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 117
TABLE 55 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 117
TABLE 56 US: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 57 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 118
TABLE 58 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 119
10.2.2 CANADA 119
10.2.2.1 Lateral flow assay components market in Canada is estimated to grow at a relatively lower rate than the US 119
TABLE 59 CANADA: MACROECONOMIC INDICATORS 119
TABLE 60 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 120
TABLE 61 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 120
TABLE 62 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 120
TABLE 63 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 121
TABLE 64 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 65 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 122
TABLE 66 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 122
10.3 EUROPE 122
TABLE 67 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 123
TABLE 68 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 123
TABLE 69 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 123
TABLE 70 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 124
TABLE 71 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 124
TABLE 72 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 125
TABLE 73 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 125
TABLE 74 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 126
10.3.1 GERMANY 126
10.3.1.1 Growing demand for POC testing to drive the lateral flow assay components market in Germany 126
TABLE 75 GERMANY: MACROECONOMIC INDICATORS 126
TABLE 76 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 127
TABLE 77 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 127
TABLE 78 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 127
TABLE 79 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 128
TABLE 80 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 128
TABLE 81 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 129
TABLE 82 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 129
10.3.2 FRANCE 129
10.3.2.1 High prevalence of age-related chronic diseases and infectious diseases to drive market growth in France 129
TABLE 83 FRANCE: MACROECONOMIC INDICATORS 130
TABLE 84 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 130
TABLE 85 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 130
TABLE 86 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 131
TABLE 87 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 131
TABLE 88 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 89 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 132
TABLE 90 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 133
10.3.3 UK 133
10.3.3.1 Severe impact of the second wave of COVID-19 in the first half of 2021 resulted in higher adoption of rapid COVID tests in the UK 133
TABLE 91 UK: MACROECONOMIC INDICATORS 134
TABLE 92 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 134
TABLE 93 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 134
TABLE 94 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 135
TABLE 95 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 135
TABLE 96 UK: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 136
TABLE 97 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 136
TABLE 98 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 137
10.3.4 ITALY 137
10.3.4.1 Growing initiatives towards decentralization of medical services in Italy are contributing to the market growth in the country 137
TABLE 99 ITALY: MACROECONOMIC INDICATORS 137
TABLE 100 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 138
TABLE 101 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 138
TABLE 102 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 138
TABLE 103 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 139
TABLE 104 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 139
TABLE 105 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 140
TABLE 106 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 140
10.3.5 SPAIN 140
10.3.5.1 Increasing focus of international organizations and domestic players on the development of POC products in the country to drive market growth 140
TABLE 107 SPAIN: MACROECONOMIC INDICATORS 141
TABLE 108 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 141
TABLE 109 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 142
TABLE 110 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 142
TABLE 111 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 142
TABLE 112 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 113 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 143
TABLE 114 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 144
10.3.6 REST OF EUROPE 144
TABLE 115 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 144
TABLE 116 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 145
TABLE 117 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 145
TABLE 118 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 145
TABLE 119 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 120 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 146
TABLE 121 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 147
10.4 ASIA PACIFIC 147
FIGURE 24 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 148
TABLE 122 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 149
TABLE 123 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 149
TABLE 124 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 149
TABLE 125 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 150
TABLE 126 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 150
TABLE 127 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 151
TABLE 128 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 151
TABLE 129 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 152
10.4.1 CHINA 152
10.4.1.1 Higher exports of lateral flow assay components during the COVID-19 pandemic to drive market growth in the country 152
TABLE 130 CHINA: MACROECONOMIC INDICATORS 153
TABLE 131 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 153
TABLE 132 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 153
TABLE 133 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 154
TABLE 134 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 154
TABLE 135 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 136 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 155
TABLE 137 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 156
10.4.2 JAPAN 156
10.4.2.1 Increasing prevalence of age-related illnesses driving the growth of the lateral flow assay components market in Japan 156
TABLE 138 JAPAN: MACROECONOMIC INDICATORS 157
TABLE 139 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 157
TABLE 140 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 157
TABLE 141 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 158
TABLE 142 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 158
TABLE 143 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 144 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 159
TABLE 145 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 160
10.4.3 INDIA 160
10.4.3.1 Increasing number of local manufacturers, growing healthcare concerns, and rising income levels to propel the growth of this market 160
TABLE 146 INDIA: MACROECONOMIC INDICATORS 160
TABLE 147 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 161
TABLE 148 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 161
TABLE 149 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 161
TABLE 150 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 162
TABLE 151 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 152 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 163
TABLE 153 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 163
10.4.4 AUSTRALIA 164
10.4.4.1 Increasing prevalence of infectious diseases, especially influenza, to drive the growth of the lateral flow assay components market in Australia 164
TABLE 154 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 164
TABLE 155 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 164
TABLE 156 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 165
TABLE 157 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 165
TABLE 158 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 159 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 166
TABLE 160 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 167
10.4.5 REST OF ASIA PACIFIC 167
TABLE 161 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 167
TABLE 162 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 168
TABLE 163 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 168
TABLE 164 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 168
TABLE 165 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 169
TABLE 166 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 169
TABLE 167 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 170
 
10.5 LATIN AMERICA 170
10.5.1 HIGH DEMAND FOR HIV POC DEVICES IN THE REGION TO SUPPORT THE GROWTH OF THE MARKET 170
TABLE 168 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 171
TABLE 169 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 171
TABLE 170 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD
TYPE, 2020–2027 (USD MILLION) 171
TABLE 171 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 172
TABLE 172 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 173 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 173
TABLE 174 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 173
10.6 MIDDLE EAST & AFRICA 173
10.6.1 SIGNIFICANT SUPPORT FROM GOVERNMENTS AND GLOBAL FIRMS TOWARDS EXPANDING HEALTHCARE SERVICES DRIVES THE ADOPTION OF LATERAL FLOW ASSAYS 173
TABLE 175 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 174
TABLE 176 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 177 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 175
TABLE 178 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 175
TABLE 179 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 175
TABLE 180 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 181 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 176
TABLE 182 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 177
11 COMPETITIVE LANDSCAPE 178
11.1 OVERVIEW 178
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 178
FIGURE 25 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
11.3 REVENUE SHARE ANALYSIS FOR KEY PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
FIGURE 26 REVENUE SHARE ANALYSIS FOR THE KEY PLAYERS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 180
11.4 MARKET SHARE ANALYSIS 180
FIGURE 27 LATERAL FLOW ASSAY COMPONENTS MARKET SHARE ANALYSIS, BY KEY PLAYER (2021) 181
TABLE 183 LATERAL FLOW ASSAY COMPONENTS MARKET: DEGREE OF COMPETITION 182
11.5 R&D ASSESSMENT OF KEY PLAYERS 183
FIGURE 28 R&D EXPENDITURE: MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2018 VS. 2020 183
11.6 GEOGRAPHIC REVENUE ASSESSMENT OF KEY PLAYERS 183
FIGURE 29 GEOGRAPHIC REVENUE ASSESSMENT: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 184
11.7 COMPANY EVALUATION QUADRANT 184
11.7.1 STARS 184
11.7.2 PERVASIVE PLAYERS 184
11.7.3 EMERGING LEADERS 185
11.7.4 PARTICIPANTS 185
FIGURE 30 LATERAL FLOW ASSAY COMPONENTS MARKET: COMPANY EVALUATION MATRIX, 2021 185
11.8 COMPETITIVE BENCHMARKING 186
11.8.1 OVERALL COMPANY FOOTPRINT 186
TABLE 184 OVERALL COMPANY FOOTPRINT (17 COMPANIES) 186
TABLE 185 COMPANY FOOTPRINT: BY TYPE (17 COMPANIES) 187
TABLE 186 COMPANY FOOTPRINT: BY REGION (17 COMPANIES) 188
11.9 COMPETITIVE SCENARIO 188
11.9.1 DEALS 189
TABLE 187 DEALS, JANUARY 2019–FEBRUARY 2022 189
11.9.2 OTHER DEVELOPMENTS 189
TABLE 188 OTHER DEVELOPMENTS, JANUARY 2019–FEBRUARY 2022 189
12 COMPANY PROFILES 190
12.1 KEY PLAYERS 190
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 DANAHER CORPORATION (PALL CORPORATION AND CYTIVA LIFE SCIENCE) 190
TABLE 189 DANAHER CORPORATION: BUSINESS OVERVIEW 190
FIGURE 31 DANAHER CORPORATION: COMPANY SNAPSHOT (2020) 191
12.1.2 SARTORIUS STEDIM BIOTECH 195
TABLE 190 SARTORIUS STEDIM BIOTECH: BUSINESS OVERVIEW 195
12.1.3 MERCK KGAA 199
TABLE 191 MERCK KGAA: BUSINESS OVERVIEW 199
FIGURE 33 MERCK KGAA: COMPANY SNAPSHOT (2020) 200
12.1.4 AHLSTROM-MUNKSJÖ 204
TABLE 192 AHLSTROM-MUNKSJÖ: BUSINESS OVERVIEW 204
FIGURE 34 AHLSTROM-MUNKSJÖ: COMPANY SNAPSHOT (2020) 205
12.1.5 ADVANCED MICRODEVICES PVT. LTD. 208
TABLE 193 ADVANCED MICRODEVICES PVT. LTD.: BUSINESS OVERVIEW 208
12.1.6 DCN DIAGNOSTICS 210
TABLE 194 DCN DIAGNOSTICS: BUSINESS OVERVIEW 210
12.2 OTHER PLAYERS 211
12.2.1 FORTIS LIFE SCIENCES 211
TABLE 195 FORTIS LIFE SCIENCES: BUSINESS OVERVIEW 211
12.2.2 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD 212
TABLE 196 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD.:
BUSINESS OVERVIEW 212
12.2.3 AXIVA SICHEM BIOTECH 214
TABLE 197 AXIVA SICHEM BIOTECH: BUSINESS OVERVIEW 214
12.2.4 NUPORE FILTRATION SYSTEM 216
TABLE 198 NUPORE FILTRATION SYSTEM: BUSINESS OVERVIEW 216
12.2.5 BALLYA BIO 217
TABLE 199 BALLYA BIO: BUSINESS OVERVIEW 217
12.2.6 RUNBIO BIOTECH CO. LTD. 219
TABLE 200 RUNBIO BIOTECH CO. LTD.: BUSINESS OVERVIEW 219
12.2.7 NEENAH GESSNER 220
TABLE 201 NEENAH GESSNER: BUSINESS OVERVIEW 220
12.2.8 MAXIM BIOMEDICAL 221
TABLE 202 MAXIM BIOMEDICAL: BUSINESS OVERVIEW 221
12.2.9 CYTODIAGNOSTICS 222
TABLE 203 CYTODIAGNOSTICS: BUSINESS OVERVIEW 222
12.2.10 SENOVA GMBH 223
TABLE 204 SENOVA GMBH: BUSINESS OVERVIEW 223
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 224
13.1 DISCUSSION GUIDE 224
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 229
13.3 AVAILABLE CUSTOMIZATIONS 231
13.4 RELATED REPORTS 231
13.5 AUTHOR DETAILS 232

US Healthcare Environmental Services Market by Type (Janitorial/Core-Cleaning, Infection Control & Prevention, Front-of-house cleaning & Brand Experie...

Publisher:        MarketsandMarkets

# of Pages:        126

Rating: 

1 User License $4,950

Publication Date:  March, 2022

Price:       $4,950 / User License




1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION & SCOPE 15
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 16
1.2.2 MARKET SEGMENTATION 16
FIGURE 1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET SEGMENTATION 16
1.2.3 YEARS CONSIDERED FOR THE STUDY 17
1.3 CURRENCY 17
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 17
1.4 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 RESEARCH APPROACH 19
FIGURE 2 RESEARCH DESIGN 19
2.1.1 SECONDARY RESEARCH 20
2.1.1.1 Key data from secondary sources 21
2.1.2 PRIMARY RESEARCH 21
FIGURE 3 PRIMARY SOURCES 22
2.1.2.1 Key data from primary sources 23
2.1.2.2 Insights from primary experts 23
2.1.2.3 Breakdown of primary interviews 24
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE (SUPPLY & DEMAND SIDE) AND DESIGNATION 24
2.2 MARKET SIZE ESTIMATION 25
FIGURE 5 MARKET SIZE APPROACH – REVENUE SHARE ANALYSIS 25
FIGURE 6 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 26
FIGURE 7 DEMAND-SIDE APPROACH 28
2.3 DATA TRIANGULATION 29
FIGURE 8 DATA TRIANGULATION METHODOLOGY 29
2.4 MARKET RANKING ANALYSIS 30
2.5 ASSUMPTIONS FOR THE STUDY 30
2.6 LIMITATIONS 31
2.6.1 METHODOLOGY-RELATED LIMITATIONS 31
2.6.2 SCOPE-RELATED LIMITATIONS 31
2.7 RISK ASSESSMENT 31
TABLE 2 RISK ASSESSMENT: US HEALTHCARE ENVIRONMENTAL SERVICES MARKET 31
 
3 EXECUTIVE SUMMARY 32
FIGURE 9 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 32
FIGURE 10 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET,
BY FACILITY TYPE, 2021 VS. 2026 (USD MILLION) 33
4 PREMIUM INSIGHTS 34
4.1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET OVERVIEW 34
FIGURE 11 STRINGENT REGULATORY GUIDELINES ON INFECTION CONTROL & PREVENTION METHODS IS A KEY FACTOR DRIVING THE MARKET GROWTH 34
4.2 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE AND FACILITY TYPE 35
FIGURE 12 JANITORIAL/CORE-CLEANING SERVICES ACCOUNTED FOR THE LARGEST SHARE OF THE US HEALTHCARE ENVIRONMENTAL SERVICES
MARKET IN 2020 35
4.3 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE (2021–2026) 36
FIGURE 13 ACUTE CARE FACILITIES TO DOMINATE THE US HEALTHCARE ENVIRONMENTAL SERVICES MARKET DURING THE FORECAST PERIOD 36
5 MARKET OVERVIEW 37
5.1 INTRODUCTION 37
5.2 MARKET DYNAMICS 37
TABLE 3 MARKET DYNAMICS: HEALTHCARE ENVIRONMENTAL SERVICES MARKET 37
5.2.1 MARKET DRIVERS 38
5.2.1.1 Increasing prevalence of Hospital-acquired infections (HAIs) 38
5.2.1.2 Rising number of hospital admissions and surgeries 39
TABLE 4 US: PERCENTAGE INCREASE IN THE NUMBER OF SURGERIES PERFORMED 39
FIGURE 14 TOTAL ADMISSIONS IN ALL US HOSPITALS 40
FIGURE 15 TOTAL NUMBER OF HOSPITALS IN THE US 40
5.2.1.3 Shortage of in-house expertise and the rising need to reduce healthcare costs 41
5.2.1.4 Increasing outsourcing of cleaning services 41
5.2.2 MARKET RESTRAINTS 41
5.2.2.1 Healthcare facilities with an in-house EVS department 41
5.2.3 MARKET OPPORTUNITIES 42
5.2.3.1 Sustained acquisitions among strategic & financial buyers 42
TABLE 5 COMPANY ACQUISITIONS 42
5.2.4 MARKET CHALLENGES 42
5.2.4.1 Noncompliance with cleaning standards by EVS providers 42
5.3 INDUSTRY TRENDS 43
5.3.1 EMERGENCE OF NEW SURFACE DISINFECTANTS &
GREEN CLEANING PRODUCTS 43
5.3.2 DISINFECTION ROBOTS 44
5.3.3 MONITORING TOOLS FOR CLEANING QUALITY ASSESSMENT 44
5.4 TECHNOLOGY ANALYSIS 45
TABLE 6 TECHNOLOGY INNOVATION IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 45
5.5 PATENT ANALYSIS 45
5.5.1 PATENT PUBLICATION TRENDS FOR HEALTHCARE ENVIRONMENTAL SERVICES 46
FIGURE 16 PATENT PUBLICATION TRENDS (JANUARY 2011–DECEMBER 2021) 46
5.5.2 JURISDICTION AND TOP APPLICANT ANALYSIS 47
FIGURE 17 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 47
FIGURE 18 TOP APPLICANT COUNTRIES/REGIONS FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 48
TABLE 7 LIST OF PATENTS/PATENT APPLICATIONS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET, 2020–2021 48
5.6 IMPACT OF COVID-19 ON THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 50
6 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE 51
6.1 INTRODUCTION 52
TABLE 8 US: HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 52
6.2 JANITORIAL SERVICES/CORE-CLEANING SERVICES 52
6.2.1 MANDATORY REGULAR CLEANING AND DISINFECTION OF HEALTHCARE FACILITIES TO DRIVE THE MARKET GROWTH 52
6.3 INFECTION PREVENTION & CONTROL SERVICES 53
TABLE 9 US: INFECTION PREVENTION & CONTROL SERVICE MARKET, BY TYPE,
2019–2026 (USD MILLION) 53
6.3.1 SPECIALIZED CLEANING SERVICES 53
6.3.1.1 Rising adoption of specialized services to reduce HAIs to drive the market growth 53
6.3.2 INFECTION PREVENTION & CONTROL CONSULTATION SERVICES 53
6.3.2.1 The provision of customized environmental services specific
to a healthcare facility ensures market demand 53
6.4 ENHANCED CLEANING TECHNOLOGY 54
6.4.1 RISING DEMAND FOR ADVANCED CLEANING SOLUTIONS TO DRIVE THE SEGMENT GROWTH 54
TABLE 10 EXAMPLES OF COMPANIES PROVIDING TECHNOLOGY & INNOVATION IN HEALTHCARE EVS 54
6.5 FRONT-OF-HOUSE CLEANING AND BRAND EXPERIENCE 56
6.5.1 RISING AWARENESS TOWARDS A CLEAN AND SAFE ENVIRONMENT DURING PANDEMICS TO SUSTAIN THE MARKET GROWTH 56
6.6 OTHER SERVICES 56
 
7 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE 57
7.1 INTRODUCTION 58
FIGURE 19 STATES WITH THE HIGHEST NUMBER OF COVID-19 ADMISSIONS
(FEBRUARY 2022) 58
TABLE 11 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE, 2019–2026 (USD MILLION) 59
7.2 ACUTE-CARE FACILITIES 59
TABLE 12 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR ACUTE-CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 59
7.2.1 ACUTE HOSPITALS 60
7.2.1.1 Increasing hospital admissions due to COVID-19 and the rising prevalence of HAIs propel the market growth 60
FIGURE 20 NUMBER OF HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS
IN THE US (2020) 60
FIGURE 21 HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS IN THE US (2020) 61
FIGURE 22 HAIS REPORTED BY CRITICAL ACCESS HOSPITALS (CAHS) IN THE US (2018) 61
7.2.2 MILITARY TREATMENT FACILITY 61
7.2.2.1 The increasing number of military ambulatory health services & funding to drive the market growth 61
FIGURE 23 MILITARY HEALTH SYSTEMS FACILITIES IN THE US (2021) 62
7.2.3 CHILDREN’S HOSPITALS 62
7.2.3.1 Rising cases of COVID-19 and infection-related mortality rates among children drive the market growth 62
7.2.4 AMBULATORY SURGERY CENTERS (ASCS) 63
7.2.4.1 ASCs save time and reduce the risk of HAIS; key factor driving the market growth 63
FIGURE 24 US SURGERY CASES BY SETTING: ASC VS. HOPD (2005-2020) 64
7.2.5 ACADEMIC MEDICAL CENTERS (AMCS) 64
7.2.5.1 Healthcare capacity expansion during COVID-19 drives the adoption of healthcare environmental services in AMCs 64
7.3 POST-ACUTE CARE FACILITIES 64
TABLE 13 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR POST-ACUTE CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 65
7.3.1 LONG-TERM ACUTE HOSPITALS (LTACH) 65
7.3.1.1 Increasing risk of infection due to prolonged hospital stays to drive the market growth 65
7.3.2 SKILLED NURSING FACILITIES (SNF) 66
7.3.2.1 Increasing admissions of elderly people in skilled nursing facilities to drive the market growth 66
7.3.3 OTHER POST-ACUTE CARE FACILITIES 66
7.4 NON-ACUTE CARE FACILITIES 67
TABLE 14 US: ENVIRONMENTAL SERVICES MARKET FOR NON-ACUTE CARE SETTINGS, BY TYPE, 2019–2026 (USD MILLION) 67
7.4.1 PHYSICIAN’S OFFICES AND CLINICS 67
7.4.1.1 High patient traffic leads to continuous cleaning & maintenance to drive the market growth 67
7.4.2 OTHER NON-ACUTE CARE FACILITIES 68
FIGURE 25 DISTRIBUTION OF INDUSTRY MEDICAL AND HEALTH R&D INVESTMENTS,
BY SEGMENT (2020) 68
8 COMPETITIVE LANDSCAPE 70
8.1 OVERVIEW 70
8.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 70
8.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 71
8.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 72
8.4 MARKET RANKING ANALYSIS 73
FIGURE 27 US HEALTHCARE ENVIRONMENTAL SERVICE MARKET RANKING,
BY KEY PLAYER, 2020 73
8.5 COMPETITIVE BENCHMARKING 75
TABLE 15 FOOTPRINT OF COMPANIES IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 75
TABLE 16 SERVICE FOOTPRINT OF COMPANIES 76
TABLE 17 END-USER FOOTPRINT OF COMPANIES 77
8.6 COMPETITIVE LEADERSHIP MAPPING 77
8.6.1 STARS 78
8.6.2 EMERGING LEADERS 78
8.6.3 PERVASIVE PLAYERS 78
8.6.4 PARTICIPANTS 78
FIGURE 28 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET:
COMPETITIVE LEADERSHIP MAPPING (2021) 79
8.7 COMPETITIVE SCENARIO 80
8.7.1 SERVICE APPROVALS/ENHANCEMENTS 80
8.7.2 DEALS 81
TABLE 19 DEALS, 2018–2022 81
8.7.3 OTHER DEVELOPMENTS 82
9 COMPANY PROFILES 83
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
9.1 SODEXO GLOBAL 83
TABLE 21 SODEXO GLOBAL: BUSINESS OVERVIEW 83
FIGURE 29 SODEXO GLOBAL: COMPANY SNAPSHOT (2021) 84
9.2 COMPASS GROUP (CROTHALL HEALTHCARE (US)) 87
TABLE 22 COMPASS GROUP: BUSINESS OVERVIEW 87
FIGURE 30 COMPASS GROUP: COMPANY SNAPSHOT (2021) 88
 
9.3 ARAMARK CORPORATION 90
TABLE 23 ARAMARK CORPORATION: BUSINESS OVERVIEW 90
FIGURE 31 ARAMARK CORPORATION: COMPANY SNAPSHOT (2021) 91
9.4 HOSPITAL HOUSEKEEPING SYSTEMS (HHS) (US) 94
TABLE 24 HOSPITAL HOUSEKEEPING SYSTEMS (HHS): BUSINESS OVERVIEW 94
9.5 HEALTHCARE SERVICES GROUP, INC. 97
TABLE 25 HEALTHCARE SERVICES GROUP, INC.: BUSINESS OVERVIEW 97
FIGURE 32 HEALTHCARE SERVICES GROUP: COMPANY SNAPSHOT (2020) 98
9.6 ABM INDUSTRIES INCORPORATED 100
TABLE 26 ABM INDUSTRIES INCORPORATED: BUSINESS OVERVIEW 100
FIGURE 33 ABM INDUSTRIES INCORPORATED: COMPANY SNAPSHOT (2020) 101
9.7 OCTOCLEAN 103
TABLE 27 OCTOCLEAN: BUSINESS OVERVIEW 103
9.8 SERVICEMASTER CLEAN (SERVICEMASTER TBS) 105
TABLE 28 SERVICEMASTER CLEAN.: BUSINESS OVERVIEW 105
9.9 CORVUS JANITORIAL SYSTEMS 107
TABLE 29 CORVUS JANITORIAL SYSTEMS: BUSINESS OVERVIEW 107
9.10 BRAVO! BUILDING SERVICES 109
TABLE 30 BRAVO! BUILDING SERVICES: BUSINESS OVERVIEW 109
9.11 POWERLINK ENVIRONMENTAL SERVICES, LLC 111
TABLE 31 POWERLINK ENVIRONMENTAL SERVICES, LLC: BUSINESS OVERVIEW 111
9.12 JANI-KING INTERNATIONAL, INC. 112
TABLE 32 JANI- KING INTERNATIONAL, INC: BUSINESS OVERVIEW 112
9.13 AVI FOOD SYSTEMS(US) 114
TABLE 33 AVI FOOD SYTEMS, INC.: BUSINESS OVERVIEW 114
9.14 SERVICON 115
TABLE 34 SERVICON: BUSINESS OVERVIEW 115
9.15 XANITOS, INC. 117
TABLE 35 XANITOS, INC.: BUSINESS OVERVIEW 117
9.16 STATHAKIS 119
TABLE 36 STATHAKIS: BUSINESS OVERVIEW 119
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
10 APPENDIX 120
10.1 INSIGHTS FROM INDUSTRY EXPERTS 120
10.2 DISCUSSION GUIDE 121
10.3 KNOWLEDGESTORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL 124
10.4 AVAILABLE CUSTOMIZATIONS 126
10.5 RELATED REPORTS 126
10.6 AUTHOR DETAILS 127